Digitally delivered cognitive behavioral therapy for insomnia (CBT-I) for patients with chronic pain and insomnia (The Back2Sleep Trial): study protocol for a randomized controlled trial
Authors:
- Maria Louise Stage OlsenMOMaria Louise Stage Olsen
- Jonas Bloch ThorlundJTJonas Bloch Thorlund
- Robert ZachariaeRZRobert Zachariae
- Werner VachWVWerner Vach
- Julie JespersenJJJulie Jespersen
- Preben KidmosePKPreben Kidmose
- Christine ParsonsCPChristine Parsons
- Kristian KidholmKKKristian Kidholm
- Henrik Bjarke VægterHVHenrik Bjarke Vægter
Open Access
- 15 August 2025
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 26 (1) , 1-15
Abstract
More than half of individuals with chronic pain also experience insomnia. Cognitive behavioral therapy for insomnia (CBT-I) is an effective and safe first-line treatment; however, access remains a major barrier to widespread implementation. This study aims to evaluate the effectiveness of a 9-week app-delivered CBT-I intervention, compared to an app-delivered sleep hygiene education program (active control), in reducing insomnia and pain severity in patients with disabling chronic pain and comorbid insomnia. The trial is a 1:1 randomized, single-blind, superiority trial randomizing 160 patients with disabling chronic pain and comorbid insomnia to either app-delivered CBT-I for 9 weeks or app-delivered sleep hygiene education for 9 weeks. Primary outcomes are the between-group differences in change in Insomnia Severity Index (ISI) and average pain intensity assessed using a 0–10 numeric rating scale (NRS) from baseline to post-interventions. Short-term secondary outcomes post-intervention include perceived effects on sleep and pain (Global Perceived Effect scales), sleep quality, thoughts and beliefs about sleep and pain, physical and mental health, and EQ5D-5L. Medium-term and long-term secondary outcomes (ISI, pain intensity, EQ5D-5L, health care costs, and use of sleep and pain medication) will be collected after 24 and 52 weeks. Exploratory physiological sleep metrics from at-home ear-electroencephalography (EEG) will be collected for five nights at baseline and for five nights during week 8. This planned study addresses a critical need for identifying effective, safe, and easily accessible alternatives to the current treatments for patients with chronic pain and insomnia. ClinicalTrials.gov NCT06361914. Registered on April 17, 2024.Keywords
All Related Versions
Funding Information
- Health Insurance Denmark (2022-0020)
- Region Syddanmark (2024-0038, 2024-0027)
- University of Southern Denmark
This publication has 49 references indexed in Scilit:
- Faculty Opinions recommendation of Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report.2015
- Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendationsPain, 2009
- Global Rating of Change Scales: A Review of Strengths and Weaknesses and Considerations for DesignJournal of Manual & Manipulative Therapy, 2009
- Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND studyRheumatology, 2008
- Dysfunctional Beliefs and Attitudes about Sleep (DBAS): Validation of a Brief Version (DBAS-16)SLEEP, 2007
- Clinical Management of Insomnia Using Cognitive TherapyBehavioral Sleep Medicine, 2006
- Core outcome measures for chronic pain clinical trials: IMMPACT recommendationsPain, 2005
- Effects of sleep and sleep loss on immunity and cytokinesBrain, Behavior, and Immunity, 2002
- Self-Reported Sleep and Mood Disturbance in Chronic Pain PatientsThe Clinical Journal of Pain, 1998
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989